End-payors seek rehearing in US appeal of Niaspan antitrust case
MLex Summary: Niaspan end-payors asked a US appeals court to rehear their case accusing AbbVie and Teva Pharmaceuticals of conspiring to delay generic Niaspan. “When pharmaceutical companies engage in anticompetitive conduct, a...To view the full article, register now.
Already a subscriber? Click here to view full article